How We Help

Donated to NET cancer research
Annual visitors to online resources
Annual patient email and phone inquiries
Patient & caregiver education sessions

NET Cancer is the FASTEST growing class of CANCER worldwide


Neuroendocrine Tumours (NETs) Overview

  • Neuroendocrine tumours (NETs) are abnormal growth of cells (neoplasms) that arise from cells of the diffuse neuroendocrine system.
  • NETs are considered complex tumours because both tumor growth and hormonal function must be addressed.
  • NETs are most common in the lung or gastrointestinal system, but they can also originate in other parts of the body such as the thyroid, thymus, pancreas, adrenals, paraganglia, ovaries and testes.
  • NETs are classified as functional (produce hormones that cause symptoms), or non-functional (may or may not produce hormones and do not cause hormonal symptoms).
  • The cause of NETs is currently unknown.

Contact Us For Live Support

Support Lines:


Toll Free: 1-844-628-6788

Latest CNETS Canada News


October 27th, 2016|0 Comments

Media Advisory “LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare type of cancer called NETs [...]

PRRT Clinical Trial Update – PMH Site

October 19th, 2016|0 Comments

On October 2, 2016, CNETS Canada held a Toronto Patient Education Day entitled PRRT Clinical Trial Update – PMH Site, with presentations by Dr. Rebecca Wong and Dr. Shereen Ezzat.  There were 30 attendees, an [...]

ESMO 2016 NET News

October 13th, 2016|0 Comments

Clinical benefit demonstrated with everolimus and pasireotide LAR alone or in combination in the first randomised, prospective study entirely dedicated to advanced lung and thymic carcinoids. In patients with advanced lung or thymus carcinoid receiving [...]

Survey on the Canadian NET Cancer Patient Experience with the Gallium 68 Scan

October 7th, 2016|0 Comments

CNETS Canada is looking to gain insight into the Canadian neuroendocrine (NET) cancer patient experience with Gallium 68 scans to date. This information will assist us in developing next steps in our advocacy work in [...]

Donate to CNETS Canada